POSTMARKETING STUDIES OF DRUG EFFICACY - WHEN MUST THEY BE RANDOMIZED

被引：40

作者：

STROM, BL

MIETTINEN, OS

MELMON, KL

机构：

[1] HARVARD UNIV,SCH PUBL HLTH,DEPT EPIDEMIOL,BOSTON,MA 02115

[2] HARVARD UNIV,SCH PUBL HLTH,DEPT BIOSTAT,BOSTON,MA 02115

[3] STANFORD UNIV,MED CTR,SCH MED,DEPT MED,DIV CLIN PHARMACOL,STANFORD,CA 94305

[4] STANFORD UNIV,MED CTR,SCH MED,DEPT PHARMACOL,STANFORD,CA 94305

[5] UNIV CALIF SAN FRANCISCO,DIV CLIN PHARMACOL,SAN FRANCISCO,CA 94143

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1983年 / 34卷 / 01期

关键词：

D O I：

10.1038/clpt.1983.119

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：1 / 7

页数：7

相关论文

共 28 条

[1] BURKHARDT R, 1978, LANCET, V2, P1356
[2] RANDOMIZED CLINICAL-TRIALS - PERSPECTIVES ON SOME RECENT IDEAS
BYAR, DP
SIMON, RM
FRIEDEWALD, WT
SCHLESSELMAN, JJ
DEMETS, DL
ELLENBERG, JH
GAIL, MH
WARE, JH
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1976, 295 (02) : 74 - 80
[3] CAMPBELL DT, 1963, EXPT QUASIEXPERIMENT, P10
[4] CASE FOR CLINICAL-TRIALS
CARBONE, PP
[J]. CA-A CANCER JOURNAL FOR CLINICIANS, 1980, 30 (01) : 53 - 54
[5] CONTROLLED STUDIES IN CLINICAL CANCER RESEARCH
CHALMERS, TC
BLOCK, JB
LEE, S
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1972, 287 (02) : 75 - &
[6] SHOULD PLACEBO-CONTROLLED TRIALS BE ABOLISHED
FEINSTEIN, AR
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 17 (01) : 1 - 4
[7] STANDARDS FOR PUBLICATION OF THERAPEUTIC RESEARCH
FEINSTEIN, AR
[J]. JOURNAL OF CHRONIC DISEASES, 1980, 33 (02): : 65 - 66
[8] NON-RANDOMIZED CONTROLS IN CANCER CLINICAL TRIALS
GEHAN, EA
FREIREICH, EJ
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1974, 290 (04) : 198 - 203
[9] RANDOMIZATION OF HUMAN SUBJECTS
GILBERT, JP
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1974, 291 (24) : 1305 - 1306
[10] THE CLINICAL TRIAL
HILL, AB
[J]. BRITISH MEDICAL BULLETIN, 1951, 7 (04) : 278 - 282